Busuttil R W, Colonna J O, Hiatt J R, Brems J J, el Khoury G, Goldstein L I, Quinones-Baldrich W J, Abdul-Rasool I H, Ramming K P
Department of Surgery, UCLA School of Medicine.
Ann Surg. 1987 Oct;206(4):387-402. doi: 10.1097/00000658-198710000-00001.
A clinical program in liver transplantation was begun at UCLA in 1984 after a period of laboratory investigation. The first 100 orthotopic liver transplants (OLT) were performed in 83 patients (43 adults and 40 children) between February 1, 1984 and November 1, 1986. Donors and recipients were matched only for size and ABO blood group compatibility, with OLT performed across blood groups in 28 patients. Standard operative techniques were used, including venous-venous bypass in adults. Arterial reconstruction was performed using an aortic Carrel patch or "branch patch" in 65% of cases and by end-to-end or aortic conduit techniques in the remainder. The hepatic artery thrombosis rate was 5%. Biliary reconstruction was choledochocholedochostomy in 67 OLT and Roux-en-Y choledochojejunostomy in 33 (complication rate of 24% and 24%, respectively). Average lengths and ranges of donor liver ischemia, operating time, and blood replacement were 4 hours (range: 1-10 hours), 7.6 hours (range: 4-15 hours), and 17 units packed cells (range: 2-220 units). Immunosuppressive regimen was cyclosporine-steroid combination, with monoclonal anti-T-cell antibody (OKT3) used for refractory rejection. All patients had one or more complications: pulmonary (78%), infectious (51%), renal dialysis (25%), neurologic (22%). All patients had at least one episode of acute rejection, and 3.6% had chronic rejection. Retransplantation was needed in nine patients once and in four patients twice. The overall retransplant survival rate was 54%, and two of four patients who received a second retransplant are alive. Sixty-three of the 83 patients (76%) are alive (adults 72%, children 80%). The 1- and 2-year actuarial survival rate is 73% (adults 68%, children 78%). Thirty-eight of 43 patients (88%) who had transplantation in the past year are alive. Of 14 perioperative variables assessed as predictors of early mortality, only postoperative dialysis (p less than 0.0005) and presence of severe rejection (p less than 0.01) had statistical significance. Seventy per cent of adults returned to work, and 84% of children had normal or accelerated growth. A new program in liver transplantation provides a dramatic option in patient care and an academic stimulus to the entire medical center.
经过一段时间的实验室研究后,加州大学洛杉矶分校于1984年启动了一项肝移植临床项目。在1984年2月1日至1986年11月1日期间,对83例患者(43名成人和40名儿童)进行了首批100例原位肝移植(OLT)。供体和受体仅在大小和ABO血型相容性方面进行匹配,28例患者进行了跨血型的OLT。采用标准手术技术,成人采用静脉-静脉转流。65%的病例采用主动脉卡雷尔补片或“分支补片”进行动脉重建,其余病例采用端端吻合或主动脉导管技术。肝动脉血栓形成率为5%。67例OLT的胆管重建采用胆总管-胆总管吻合术,33例采用Roux-en-Y胆总管空肠吻合术(并发症发生率分别为24%和24%)。供肝缺血、手术时间和输血量的平均时长及范围分别为4小时(范围:1 - 10小时)、7.6小时(范围:4 - 15小时)和17单位浓缩红细胞(范围:2 - 220单位)。免疫抑制方案为环孢素 - 类固醇联合用药,难治性排斥反应时使用单克隆抗T细胞抗体(OKT3)。所有患者均有一个或多个并发症:肺部(78%)、感染(51%)、肾透析(25%)、神经病变(22%)。所有患者至少有一次急性排斥反应发作,3.6%有慢性排斥反应。9例患者需要进行一次再次移植,4例患者需要进行两次再次移植。再次移植的总体生存率为54%,接受第二次再次移植的4例患者中有2例存活。83例患者中有63例(76%)存活(成人72%,儿童80%)。1年和2年的精算生存率分别为73%(成人68%,儿童78%)。过去一年接受移植的43例患者中有38例(88%)存活。在评估为早期死亡预测因素的14个围手术期变量中,只有术后透析(p < 0.0005)和严重排斥反应的存在(p < 0.01)具有统计学意义。70%的成人恢复工作,84%的儿童生长正常或加速。一项新的肝移植项目为患者护理提供了一个重大选择,并对整个医疗中心起到了学术推动作用。